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1. Introduction 
Muscarinic acetylcholine receptors have been 
detected in many tissues using the radio-ligand bind- 
ing technique [ 11. The electric organ of Z’orpedo spe- 
cies has been used extensively for studying the cho- 
linergic synapse [2] and particularly for characterizing 
the nicotinic acetylcholine receptor [3] and in [4-61 
a muscarinic acetylcholine receptor in this tissue has 
been shown using the radio-ligand binding technique. 
The muscarinic acetylcholine receptors in lbvpedo 
electric organ are probably entirely presynaptic [5,6] 
and so may provide a useful system for studying any 
differences between presynaptic and postsynaptic 
muscarinic receptors. Here we describe the ligand- 
binding characteristics of the Torpedo receptor and 
the effect of guanine nucleotides on ligand-binding to 
the receptor. 
2. Materials and methods 
Torpedo ~~~~~a~a were obtained from the Station 
Biologique d’kcachon, France and were kept in cir- 
culating sea water tanks in Nottin~~ at 12-15°C. 
d-Tubocurarine chloride, decamethonium bromide, 
phenylmethane sulphonyl fluoride and guanine 
nucleotides were obtained from Sigma (London) 
Chemical Co., Poole, Dorset. All other chemicals were 
obtained from suppliers given in [7,8]. 
Electric organ membrane fragments were prepared 
from fresh tissue or tissue stored at -8O’C. An homog- 
enate (20%, w/v, in ice-cold 0.25 M sucrose, 0.1 mM 
EDTA, 0.02 mM phenylmethane sulphonyl fluoride) 
was prepared using a MSE topdrive homogenizer at 
full speed for 2 mm. The homogenate was sonicated 
(3 min, 4’C) and centrifuged for 20 min at 2000 X g,. 
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The supernat~t was removed and centrifuged for 
120 min at 143 000 X gav to give a pellet which was 
either resuspended in an ice cold Hepes-phosphate- 
saline buffer (pH 7.4) [S] at -IO mg protein/ml 
(determined as in [9]) (P preparation) or resuspended 
in 0.25 M sucrose (at -5 mg protein/ml) and applied 
to the top of a stepwise sucrose gradient containing 
layers of equal volumes of 0.4 M sucrose and 1 M 
sucrose. After centrifugation (100 000 X g,, 4 h) the 
band between the 0.4 M and 1 M sucrose layers was 
removed, diluted 3-fold in buffer and centrifuged 
(140 000 X gav, 3 h). The pellet was resuspended in 
buffer at -5 mg protein/ml (Pn preparation). 
Muscarinic acetylcholine receptor binding was 
determined as follows: electric organ membrane frag- 
ments (0.2-I .O mg/ml) were incubated in a final 
volume of 4.25 ml Hepes-phosphate-saline buffer 
[8] containing [3-“Hlquinuclidinyl benzilate ([3-3H]- 
QNB) (50 pM- 8 nM) and other drugs where appro- 
priate at 30°C for 30 min or 60 min. At the end of 
the incubation, four 1 ml aliquots were removed and 
filtered under vacuum through separate presoaked 
GF/F glass Iibre filters ~atrn~) which were washed 
with 2 ml buffer at 20°C. ~dioactiv~ty trapped on 
the filters was determined as in [8]. 
For atropine and [ 3-3H] QNB racemic mixtures of 
the compounds were used but it was assumed that 
only the (-)-isomers were pharmacologically active 
[7,8]. Specific (-)-[3-3H]QNB binding (-80% of 
total binding) was defined as that displaceable by 20 
PM atropine [7,8]. Binding parameters were deter- 
mined from Scatchard plots and by use of the equa- 
tion : 
Log (fractional occup~cy~l-fractional occupancy) = 
n Log [ligand]- n Log IC,, 
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KS0 = ([ligand] giving 50% occupancy); 12 = slope fac- 
tor (equivalent to a Hill coefficient for saturation 
binding experiments [IO]). 
3. Results and discussion 
In preliminary experiments using an homogenate 
of Torpedo marmorata electric organ a significant but 
low number of muscarinic acetylcholine receptors was 
detected (-50 fmol/mg protein). For more detailed 
work the homogenate was subfractionated in order to 
increase the specific activity of binding either by dif- 
ferential centrifugation (P preparation) or by differ- 
ential and sucrose density gradient centrifugation (PB 
preparation). Enrichments of binding were obtained 
in both preparations: P 175 f 34 (6) fmol/mg protein; 
PB 337 + 122 (4) fmol/mg protein (mean f SD (no. 
expt.)). The binding of [3-311]QNB to either prepara- 
tion was saturable (fig.1): dissociation constants for 
(-)-[3-3H]QNB were 235 f 5 pM (P) and 38 + 4 pM 
(PB) (mean f range, 2 expt.). These values are similar 
to those obtained using other tissues [7,11]. Subcellu- 
lar fractionation studies (not shown) have suggested 
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Fig.1. Specific binding of [ 3-3H]QNB to Torpedo electric 
organ membrane preparations. Specific binding of [ 3-3H]- 
QNB was determined as described to P (0) and PB (A) prep- 
arations. Data are expressed as % of maximum binding 
(determined by Scatchard analysis) and the lines are theoret- 
ical binding curves for binding to a single class of sites (Kd 
0.24 nM (P); Kd 0.035 nM (PB)). Each point is the mean of 
a quadruplicate determination. 
Table 1 
Ligand-binding properties of muscarinic acetylcholine receptors 
______ 
Ligand Torpedo Rat cerebral cortex [ 11 ,131 
Antagonists Kd (M) Slope Kd (M) Slope 
factor factor 
(-)-Atropine 1.2 X 10m9 (a) 1.31 5.5 x lo-l0 0.95 
(-)-Quinuclidinyl 3.8 X lo-” (a) 0.82 
benzilate 1 2.4 X 10-r’ (b) 0.83 I 
1.4 x 10-‘O 1.09 
(()-Scopolamine 1.3 X 10e9 (a) 1.03 8.1 X lo-” 1.01 
Corr . IC,, Slope IC,, (M) Slope 
Agonists (M) factor factor 
Arecoline 2.6 X 1O-6 (b) 0.65 5.0 x 1o-6 0.15 
Carbamoylcholine 11.5 X low6 (a) 0.601 1.5 x 1o-5 0.33 
17.5 X lo-” (b) 0.61) 
Oxotremorine-M (c) 3.3 x lo-’ (b) 0.47 1.6 x 1O-6 0.25 
Nicotinic acetylcholine 
receptor ligands 
Decamethonium 7.3 X 10W6 (a) - _ _ 
d-Tubocurarine 2.3 X 10m5 (a) - _ 
Ligand-binding properties were determined from displacement or saturation bind- 
ing experiments as described using PB preparation (a) or P preparation (b). ZC,, 
values from displacement experiments were corrected for receptor occupancy 
[7,8] to give Kd or corrected IC,, values. (c) [ 131 
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the presence of a sofuble inhibitor of f3-3H] QNB- 
binding in Topped0 electric organ. The increased affm- 
ity of (3”3~i]QN~-b~nd~ng accornp~y~~g further puri- 
ficatian of the P preparation might therefore reflect 
the removal of this endogenous inhibitor. Although 
the identity of this inhibitor has not been established 
a hkely candidate is choline which has been shown to 
inhibit binding af [3-3H]QNB to muscarinic receptors 
in mammalian brain [ 121. 
The binding properties of other ligands were stud- 
ied by displacement of [3-3H] QN~-biding (table 1, 
fig.2). The seledive nicotinic acetylcholine receptor 
ligands dec~~thonium and tubocurarine were rela- 
tively poor inhibitors whereas the specific muscarinie 
a~etyl~ho~ine receptor hgands atropine and scopol- 
amine were potent inhibitors of [3-3H]QNB binding 
cont%ming the muscarinic nature of the binding sites 
{table 1). 
The binding of the antagonists ested (atropine, 
QNB, scopolamine) was characterized by slope factors 
close to one indicating that binding was at a single 
class of sites. The values of the dissociation constants 
for these ligands were comparable with values obtained 
in other tissues f f If. Agonist binding was character- 
ized by slope factors of <f indicating some complexity 
in be~av~our. The ~~~e~~ receptor, therefore, con- 
forms to the general pattern observed for Iigand bind- 
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FC.2. Effect of GTP on ligand-binding to the Torpedo mus- 
carinic acetylcholine receptor. The binding af f-)-atropine 
and carbamoyicho~ne was assayed by displacement of 
[ 3-3 H]QNB binding from a P preparation in the presence 
((0) (--)-apropos; (=) c~bamoylcho~a) and absence f(b) 
(-Wropine; (01 c~bamoylcho~me) of 0.1 mM GTP. Each 
point is the mean of a ~uadrupii~te determination. For 
atropine the line is a theoretical biding curve for I%,, = 
3.2 nM. 
ing at muscarin~~ receptors in other tissues [11,13]: 
antagonist binding is at a single class of sites whereas 
agonist binding is more complex. When examined in 
detail, however, the Torpedo receptor shows differ- 
ences from receptors in other tissues. Compared to 
the rat cerebral cortical receptor [11,13], although 
affinities for antagonist binding are similar, the 
Torpedo receptor shows higher agonist affinities and 
the slope factors for agonist binding are greater 
(table 1). 
These differences may reflect the different species 
used for the experiments (Torpedo vs rat> but they 
may also reflect the location of the receptors: the 
Toqxa’tt receptors are presynapt~e whereas the cere- 
bral cortical receptors are likely to be both presyn- 
aptic and ~stsynaptic. 
fn order to investigate these possibilities further 
we have tested the effect of guanine nucleotides on 
the Torpedo muscatinic receptor binding properties 
(fig.2). Guanosine triphosphate (GTP) (0.1 mM) did 
not affect the binding of atropine but it reduced the 
ability of carbamoylcho~ne to inhibit [3-3H]QNB 
binding (-GTP, corrected IL’,, 7.5 FM, slope factor 
0.61; f GTP, corrected &I& 25.4 PM, dope factor 
0.57). Similar effects were observed with guanosine 
d~phosphate nd guany~ylimidod~phospha~e but other 
guanine nucleotides were inactive. 
Similar agonist-specific effects of guanosine nucleo- 
tides have been reported for muscarinic receptors in 
brain and myocardium [ 14,151. In the case of myo- 
cardium the effect of GTP has been linked with mus- 
carinic inhibition of adenylate cyclase [151. This raises 
the possibility that the Torpedo muscarinic receptor 
is also associated with in~bition of adenylate cyclase. 
In conclusion, therefore, the Toledo rnnsc~ri~~c 
~cetyl~holi~e receptor shows qualitative similarities 
with musca~~c receptors in rat cerebral cortex both 
in terms of agonist and antagonist binding properties 
and the effects of guanine nucleotides. There are, 
however, quantitative differences in agonist binding 
properties which may reflect a species difference or a 
difference between presynaptic and postsynaptic 
receptors. 
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